Knee Implants Market Size & Growth Forecast 2027–2036, By Segments (Procedure, Component, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Knee Implants Market size was more than USD 8.6 billion in 2026 and is set to grow at a 3.14% CAGR between 2027 and 2036, surpassing USD 11.72 billion by 2036. The industry revenue for 2027 is calculated at USD 8.83 billion.

• Base Year Value (2026): USD 8.6 billion
• CAGR (2027-2036): 3.14%
• Forecast Year Value (2036): USD 11.72 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Knee Implants Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America led with 48.12% share, supported by high procedure volumes, advanced orthopedic infrastructure, strong specialist access, and established reimbursement and care pathways.
  • Asia Pacific is growing at 3.88% CAGR, driven by improving healthcare access, expanding surgical capacity, and rising adoption of knee replacement procedures across aging populations.

• Segment Momentum:

  • Total Knee Replacement held a 73.54% share in 2026 as it remains the standard approach for advanced or multi-compartment knee degeneration, supported by broad clinical applicability and established surgical workflows.
  • Mobile-bearing Implants are the fastest-growing component segment as increasing emphasis on motion, functional performance, and patient-specific treatment encourages adoption in selected orthopedic cases.

• Market Expansion Drivers:

  • Rising prevalence of osteoarthritis increasing demand for knee replacement procedures.
  • Growing adoption of minimally invasive orthopedic surgeries improving patient recovery outcomes.
  • Increasing sports injuries and obesity-related joint disorders expanding knee implant utilization rates.

• Leading Market Participants:

  Leading companies in the knee implants market include Zimmer Biomet Holdings Inc. (United States), Stryker Corporation (United States), Johnson & Johnson (DePuy Synthes) (United States), Smith & Nephew plc (United Kingdom), Medacta Group SA (Switzerland), MicroPort Scientific Corporation (China), B. Braun Melsungen AG (Germany), CONMED Corporation (United States), Corin Group plc (United Kingdom), Exactech Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 8.6 billion
  • 2027 Estimated Market Size: USD 8.83 billion.
  • Projected Market Size: USD 11.72 billion by 2036
  • Growth Forecasts: 3.14% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Total Knee Replacement (Procedure) | Fixed-bearing Implants (Component) | Hospitals (End-use)
  • Emerging Opportunity Segment: Partial Knee Replacement (Procedure) | Mobile-bearing Implants (Component) | Outpatient Facilities (End-use)

Market Growth Drivers and Industry Trends

Rising prevalence of osteoarthritis increasing demand for knee replacement procedures

The rising prevalence of osteoarthritis will drive the knee implants market growth as progressive joint degeneration increases pain, stiffness, mobility limitations, and the need for surgical intervention among affected patients. As conservative treatments become less effective for individuals with advanced joint damage, knee replacement procedures provide an established approach for restoring joint function and improving mobility. An aging population, longer life expectancy, and greater recognition of degenerative joint conditions are also contributing to the pool of patients requiring orthopedic care. Growing access to orthopedic evaluation and improvements in implant design are encouraging more patients and healthcare providers to consider replacement procedures when osteoarthritis significantly affects daily activities.

Growing adoption of minimally invasive orthopedic surgeries improving patient recovery outcomes

Growing adoption of minimally invasive orthopedic surgeries is supporting the knee implants market by encouraging procedures that aim to reduce tissue disruption, postoperative discomfort, and recovery time. Advances in surgical techniques, imaging assistance, and implant positioning are enabling orthopedic specialists to perform knee replacement procedures with greater procedural precision while supporting efficient rehabilitation. Improved recovery outcomes can increase patient acceptance of surgical treatment, particularly among individuals seeking to regain mobility with less disruption to daily activities. Hospitals and orthopedic centers are also adopting techniques that support shorter recovery pathways and more efficient postoperative care, increasing the relevance of compatible knee implant systems.

Increasing sports injuries and obesity-related joint disorders expanding knee implant utilization rates

Increasing sports injuries and obesity-related joint disorders are boosting knee implant utilization by contributing to cartilage deterioration, ligament damage, joint instability, and accelerated wear of the knee joint. The knee implants market benefits from the growing need for surgical treatment when traumatic injuries or excessive joint loading result in severe and persistent functional impairment. Athletes and physically active individuals may develop significant knee damage following repetitive stress or acute injuries, while excess body weight can place additional mechanical pressure on the joint and worsen degenerative conditions. The combination of injury-related and weight-associated orthopedic problems is expanding the range of patients requiring advanced knee reconstruction and replacement interventions.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of osteoarthritis increasing demand for knee replacement procedures	1.90%	Moderate	North America, Europe	High	Near Term
Growing adoption of minimally invasive orthopedic surgeries improving patient recovery outcomes	1.70%	High	Asia Pacific, North America	High	Mid Term
Increasing sports injuries and obesity-related joint disorders expanding knee implant utilization rates	1.40%	Moderate	Latin America, Asia Pacific	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the knee implants market, North America held the largest share of 48.12% in 2026, supported by advanced orthopedic healthcare infrastructure, high adoption of surgical technologies, and strong demand for joint replacement procedures. The region benefits from widespread access to specialized orthopedic care, established rehabilitation services, and growing clinical emphasis on improving mobility and quality of life among patients with degenerative joint conditions. Technological advancements in implant design and surgical techniques, along with increasing preference for durable and patient-specific treatment options, further reinforce regional demand.

Asia Pacific is emerging as the fastest-growing region, driven by improving healthcare infrastructure, rising awareness of orthopedic treatment options, and increasing access to specialized surgical services. Population aging and the growing prevalence of mobility-related conditions are creating greater demand for knee replacement procedures, while healthcare modernization is enabling more hospitals and medical centers to adopt advanced orthopedic technologies. Expanding medical capabilities and improving patient access to surgical care are expected to support continued market development across the region.

Key Country Insights

United States

Innovation Adoption Center

The U.S. knee implants market emphasizes advanced implant technologies, robotic-assisted procedures, and personalized surgical planning. Healthcare providers increasingly evaluate implant systems that improve procedural efficiency, long-term performance, and patient-specific treatment outcomes.

Japan

Aging Care Solutions

Japan's knee implants market is shaped by increasing demand for orthopedic procedures supporting mobility among older adults. Healthcare providers focus on durable implant designs, minimally invasive techniques, and rehabilitation approaches that improve postoperative recovery experiences.

South Korea

Technology-Enabled Orthopedics

South Korea continues integrating digital surgical technologies with knee implant procedures to enhance planning accuracy and clinical efficiency. The market favors implant systems compatible with modern orthopedic workflows and evolving hospital technology investments.

Germany

Precision Orthopedic Practice

Germany prioritizes knee implant solutions supported by strong clinical evidence, high manufacturing quality, and precise surgical techniques. Hospitals increasingly adopt implant systems designed to optimize procedural consistency and long-term orthopedic performance.

France

Clinical Outcome Focus

France emphasizes knee implant solutions backed by strong clinical performance and standardized treatment protocols. Procurement decisions increasingly consider implant longevity, patient recovery, and compatibility with evolving orthopedic care practices across healthcare facilities.

Italy

Hospital Procedure Optimization

Italy's knee implants market focuses on improving orthopedic procedure efficiency while addressing increasing demand for joint replacement surgeries. Healthcare providers prioritize reliable implant systems that support consistent surgical outcomes and streamlined postoperative patient management.

Segment Leadership and Growth Trends

 

Procedure Segment Analysis: Total Knee Replacement (Largest Segment) vs Partial Knee Replacement (Fastest-Growing Segment)

The total knee replacement segment dominated the knee implants market with a 73.54% share in 2026. Its leading position is supported by the widespread use of total replacement procedures for patients with advanced joint degeneration or extensive knee damage affecting multiple areas of the joint. These procedures can provide comprehensive joint reconstruction when less extensive interventions are insufficient. Rising demand for orthopedic treatment and continued advances in surgical techniques are expected to sustain the segment's substantial market presence.

The partial knee replacement segment is expected to be the fastest-growing segment as surgeons increasingly consider bone-preserving procedures for patients with localized joint damage. Partial replacement can retain unaffected portions of the knee and may offer advantages in selected patient populations. Growing emphasis on personalized orthopedic treatment and advancements in implant design and surgical planning are expected to support segment growth.

Component Segment Analysis: Fixed-bearing Implants (Largest Segment) vs Mobile-bearing Implants (Fastest-Growing Segment)

The fixed-bearing implants segment held the largest share of the knee implants market in 2026, supported by their established clinical use and relatively straightforward design. In fixed-bearing systems, the polyethylene component remains secured to the tibial baseplate, providing a stable bearing surface for joint movement. Strong familiarity among orthopedic surgeons and broad applicability across knee replacement procedures continue to support the segment's leading position.

The mobile-bearing implants segment is anticipated to be the fastest-growing segment as implant innovation increasingly focuses on designs intended to support more natural joint movement and improved functional performance. Mobile-bearing systems allow movement of the bearing component, potentially providing advantages for selected patients and surgical approaches. Continued technological development in orthopedic implant design is expected to drive further adoption.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Procedure	Total Knee Replacement, Partial Knee Replacement, Revision Knee Replacement	Total Knee Replacement	Partial Knee Replacement
Component	Fixed-bearing Implants, Mobile-bearing Implants	Fixed-bearing Implants	Mobile-bearing Implants
End-use	Hospitals, Outpatient Facilities	Hospitals	Outpatient Facilities

Competitive Landscape and Market Positioning

Major players in the knee implants market:

1. Zimmer Biomet Holdings Inc. (United States)

2. Stryker Corporation (United States)

3. Johnson & Johnson (DePuy Synthes) (United States)

4. Smith & Nephew plc (United Kingdom)

5. Medacta Group SA (Switzerland)

6. MicroPort Scientific Corporation (China)

7. B. Braun Melsungen AG (Germany)

8. CONMED Corporation (United States)

9. Corin Group plc (United Kingdom)

10. Exactech Inc. (United States)

Innovation in the knee implants market is increasingly driven by advancements in surgical technologies and continuous improvement in implant design. The knee implants market is witnessing stronger emphasis on developing precision-based solutions that improve patient recovery and long-term outcomes. Growing collaboration across the ecosystem is accelerating the introduction of next-generation implant systems, while evolving patient expectations are pushing frequent enhancements in product performance and customization.

Industry Development/News

Company Name	Date	Key Development
Zimmer Biomet	Oct-25	Zimmer Biomet agreed to acquire Monogram for approximately $177 million to bolster its robotics portfolio. This strategic investment is designed to enhance the company's capabilities in autonomous and robot-assisted orthopedic surgical systems, strengthening its competitive positioning in the high-growth robotic-assisted knee replacement market segment.
OSSTEC	Oct-25	OSSTEC secured £2.5 million in funding to accelerate the development of its 3D-printed joint replacement technology. This investment supports the advancement of next-generation orthopedic solutions, signaling a shift toward customized, patient-specific implant manufacturing and material innovation within the broader knee replacement industry.
Alkem MedTech	Oct-25	Alkem MedTech formed a strategic manufacturing and marketing agreement with Exactech for hip and knee implants in India. This partnership provides Alkem with access to advanced proprietary implant technologies, facilitating market entry and footprint expansion within the growing Indian orthopedic surgical sector.
Knee+ NexSight	Nov-25	Knee+ NexSight received U.S. regulatory clearance for its augmented reality-assisted knee replacement platform. This technological milestone enables the commercialization of advanced surgical visualization capabilities, potentially improving clinical outcomes and operational efficiency in knee replacement procedures through real-time, precision-guided intraoperative data.
Naton Biotechnology	Oct-25	Naton Biotechnology’s laser 3D-printed total knee implant received approval from China’s National Medical Products Administration. This regulatory success validates the company's advanced manufacturing capabilities for customized implants and represents a significant development in the adoption of additive manufacturing processes to improve patient-specific anatomical fit in total knee arthroplasty.
DePuy Synthes	Jun-24	DePuy Synthes, a Johnson & Johnson company, received FDA 510(k) clearance for the VELYS Robotic-Assisted Solution for Unicompartmental Knee Arthroplasty. This expansion of its robotic platform capabilities enhances the company's competitive standing in the minimally invasive surgery market, allowing for broader application of robotics across different knee replacement modalities.
Zimmer Biomet	Jun-24	Zimmer Biomet established a distribution agreement with THINK Surgical to integrate the TMINI Miniature Robotic System into its total knee arthroplasty offerings. This partnership aims to increase the reach of robotic-assisted surgical solutions, providing surgeons with enhanced precision tools and broadening the company’s portfolio in the highly competitive robotic surgery space.
Stryker	Oct-25	Stryker reported record installations of its Mako robotic platform and announced ongoing software upgrades. This operational momentum demonstrates the successful commercial scaling of robotics in orthopedics, with continuous software integration enabling expanded clinical utility and sustained market adoption of the company’s knee replacement technology.
Zimmer Biomet	Oct-25	Zimmer Biomet received FDA clearance for new cementless knee implant options. Targeted at patients with specific metal or bone cement sensitivities, this product innovation expands the company's portfolio to address unmet clinical needs and provides a specialized option for patients who may otherwise be unsuitable for standard implant materials.
Exactech	Oct-25	Exactech reached an $8 million settlement with the U.S. Department of Justice regarding defective knee implant components as part of its restructuring process. This development highlights the significant legal and operational risks associated with product quality and compliance within the implant manufacturing value chain.